LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion.

    Conzentino, Marcelo S / Forchhammer, Karl / Souza, Emanuel M / Pedrosa, Fábio O / Nogueira, Meri B / Raboni, Sônia M / Rego, Fabiane G M / Zanette, Dalila L / Aoki, Mateus N / Nardin, Jeanine M / Fornazari, Bruna / Morales, Hugo M P / Celedon, Paola A F / Lima, Carla V P / Mattar, Sibelle B / Lin, Vanessa H / Morello, Luis G / Marchini, Fabricio K / Reis, Rodrigo A /
    Huergo, Luciano F

    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology

    2021  Volume 52, Issue 4, Page(s) 2069–2073

    Abstract: ... immunization to future vaccines. Here, the SARS-CoV-2 nucleocapsid protein was expressed in Escherichia coli ... to track COVID-19 cases and determine the level of humoral response to SARS-CoV-2 infections and/or ... and purified to homogeneity and high yield using a single chromatography step. The purified SARS-CoV-2 ...

    Abstract Serological assays are important tools to identify previous exposure to SARS-CoV-2, helping to track COVID-19 cases and determine the level of humoral response to SARS-CoV-2 infections and/or immunization to future vaccines. Here, the SARS-CoV-2 nucleocapsid protein was expressed in Escherichia coli and purified to homogeneity and high yield using a single chromatography step. The purified SARS-CoV-2 nucleocapsid protein was used to develop an indirect enzyme-linked immunosorbent assay for the identification of human SARS-CoV-2 seroconverts. The assay sensitivity and specificity were determined analyzing sera from 140 RT-qPCR-confirmed COVID-19 cases and 210 pre-pandemic controls. The assay operated with 90% sensitivity and 98% specificity; identical accuracies were obtained in head-to-head comparison with a commercial ELISA kit. Antigen-coated plates were stable for up to 3 months at 4 °C. The ELISA method described is ready for mass production and will be an additional tool to track COVID-19 cases.
    MeSH term(s) Antibodies, Viral/blood ; COVID-19/diagnosis ; COVID-19/immunology ; Coronavirus Nucleocapsid Proteins/immunology ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunity, Humoral ; Nucleocapsid Proteins/genetics ; Phosphoproteins/immunology ; Sensitivity and Specificity ; Seroconversion
    Chemical Substances Antibodies, Viral ; Coronavirus Nucleocapsid Proteins ; Nucleocapsid Proteins ; Phosphoproteins ; nucleocapsid phosphoprotein, SARS-CoV-2
    Language English
    Publishing date 2021-08-03
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 2017175-4
    ISSN 1678-4405 ; 1517-8382
    ISSN (online) 1678-4405
    ISSN 1517-8382
    DOI 10.1007/s42770-021-00556-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion

    Conzentino, Marcelo dos Santos / Forchhammer, Karl / Souza, Emanuel M / Pedrosa, Fabio de Oliveira / Nogueira, Meri B / Raboni, Sonia M / Rego, Fabiane G M / Zanette, Dalila L / Aoki, Mateus N / Nardin, Jeanine M / Fornazari, Bruna / Morales, Hugo M P / Celedon, Paola A F / Lima, Carla V P / Mattar, Sibelle B / Lin, Vanessa H / Morello, Luis G / Marchini, Fabricio K / Bueno, Lucas B /
    Reis, Rodrigo A / Huergo, Luciano

    medRxiv

    Abstract: ... immunization to future vaccines. Here the SARS-CoV-2 nucleocapsid protein was expressed in Escherichia coli and ... to track COVID-19 cases and determine the level of humoral response to SARS-CoV-2 infections and/or ... purified to homogeneity and high yield using a single chromatography step. The purified SARS-CoV-2 ...

    Abstract Serological assays are important tools to identify previous exposure to SARS-CoV-2, helping to track COVID-19 cases and determine the level of humoral response to SARS-CoV-2 infections and/or immunization to future vaccines. Here the SARS-CoV-2 nucleocapsid protein was expressed in Escherichia coli and purified to homogeneity and high yield using a single chromatography step. The purified SARS-CoV-2 nucleocapsid protein was used to develop an indirect enzyme-linked immunosorbent assay for the identification of human SARS-CoV-2 seroconverts. The assay sensitivity and specificity were determined analyzing sera from 140 PCR-confirmed COVID-19 cases and 210 pre-pandemic controls. The assay operated with 90% sensitivity and 98% specificity; identical accuracies were obtained in head-to-head comparison with a commercial ELISA kit. Antigen coated plates were stable for up to 3 months at 4oC). The ELISA method described is ready to mass production and will be an additional toll to track COVID-19 cases.
    Keywords covid19
    Language English
    Publishing date 2021-02-23
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.02.19.21252100
    Database COVID19

    Kategorien

To top